

First Trust Nasdaq Artificial Intelligence and Robotics ETF (NASDAQ: ROBT - Get Free Report)'s share price reached a new 52-week high during mid-day trading on Monday. The stock traded as high as $61.08 and last traded at $61.04, with a volume of 34260 shares. The stock had previously closed at $60.19. First Trust Nasdaq Artificial Intelligence

First Trust Nasdaq Artificial Intelligence and Robotics ETF (NASDAQ: ROBT - Get Free Report) saw a large decline in short interest during the month of September. As of September 15th, there was short interest totaling 9,464 shares, a decline of 59.9% from the August 31st total of 23,606 shares. Approximately 0.1% of the company's shares are

Markets are broader than headlines suggest. AI is driving wider economic growth in Canada. Why Canada is positioned to benefit from the AI buildout.

Integrated Wealth Concepts LLC lessened its position in First Trust Nasdaq Artificial Intelligence and Robotics ETF (NASDAQ: ROBT) by 74.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,654 shares of the company's stock after selling 59,995

AI ETFs offer diversified exposure to a fast-growing sector, but wide performance gaps show why fund selection and strategy matter.

AI is everywhere in the product. But revenue growth is decelerating, from 16% to 13% to 12% guided. The productivity benefits are arriving for users and end-consumers of AI, though it's not hitting the income statement (at least yet) for most companies.

Jensen Huang has spent the past year saying the next artificial intelligence (AI) boom will land in factories, warehouses, hospitals, and on highways, where AI gets a body.

First Trust Nasdaq Artificial Intelligence and Robotics ETF is structurally flawed due to its equal-weight, 138-stock portfolio lacking a coherent AI thesis. ROBT underperforms peers during the AI supercycle, with a Sharpe ratio of 0.49 and a high 1.92 beta, failing to capture true AI infrastructure value. The fund's 0.65% expense ratio is unjustified given its passive, undifferentiated approach and mediocre returns compared to conviction-driven competitors like BOTZ and AIQ.